Risk Factors for Acquisition of Urinary Tract Infections Caused by Ciprofloxacin Resistant Escherichia Coli
- 1 January 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 153 (1) , 117-120
- https://doi.org/10.1097/00005392-199501000-00040
Abstract
From January 1990 to December 1992, ciprofloxacin resistant Escherichia coli was isolated in 125 of 1,946 urine cultures (6.4%) with more than 10 sup 5 colony-forming units per ml. To determine the risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant E. coli a retrospective chart review was done. Data from 54 patients with urinary tract infections caused by ciprofloxacin resistant E. coli were compared with 51 controls matched by temporal occurrence and randomly selected among 540 patients with urinary tract infections caused by ciprofloxacin susceptible E. coli. Patients had greater proportions of asymptomatic bacteriuria or lower urinary tract symptoms (85% versus 61%, p = 0.01) and of relapse (22% versus 0%, p = 0.001) than controls. Urinary tract abnormalities (odds ratio 7.98, 95% confidence interval 2.7 to 3.1, p <0.001), patient age 65 years or older (odds ratio 6.48, 95% confidence interval 2.2 to 19.1, p <0.001), previous treatment with quinolones (odds ratio 19.09, 95% confidence interval 2.2 to 166.5, p = 0.008) and urinary catheterization (odds ratio 2.92, 95% confidence interval 1.1 to 8.5, p = 0.048) were independently associated with infections caused by ciprofloxacin resistant strains. Our results suggest that patients with urological abnormalities previously treated with quinolones are especially prone to urinary tract infection caused by ciprofloxacin resistant strains.Keywords
This publication has 8 references indexed in Scilit:
- Ten-year survey of quinolone resistance inEscherichia coli causing urinary tract infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- The emergence of highly fluoroquinolone-resistant Eschericha coli in community-acqntred urinary tract infectionsJournal of Antimicrobial Chemotherapy, 1992
- Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinationsAntimicrobial Agents and Chemotherapy, 1990
- Bacterial mntagenicity and the 4-quinolonesJournal of Antimicrobial Chemotherapy, 1987
- Trimethoprim resistanceAntimicrobial Agents and Chemotherapy, 1987
- Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coliAntimicrobial Agents and Chemotherapy, 1986
- Investigations into the mechanism of action of the antibacterial agent norfloxacinJournal of Antimicrobial Chemotherapy, 1984
- In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprimAntimicrobial Agents and Chemotherapy, 1983